WRWajiha Rizwan

Wajiha Rizwan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Wajiha Rizwan has a total of 29 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Congenital generalized lipodystrophy Type 2 (BSCL2; OMIM #269700) presenting with muscular hypertrophy and chronic steatorrhea in a Pakistani child: a pediatric case report confirmed by real-time PCR gene analysis

    by Azhar Shah, Wajiha Rizwan Rizwan, Sana Jamil, Khaver Ali, Hira Tiwana, Sana Riaz, Tariq Javed

    Background: Congenital generalized lipodystrophy (CGL), or Berardinelli-Seip syndrome, is a rare autosomal recessive condition with near-complete lack of metabolically functional adipocytes since birth or in early infancy, leading to severe metabolic complications. The prevalence of CGL is less than 1 case per million births, and it occurs in four genetic types (CGL1-CGL4). CGL type 2 (mutations in the BSCL2 gene; OMIM #269700) is the most common subtype (70–80% of cases), and has the most severe metabolic complications. Timely diagnosis is essential to avoid potentially fatal complications by early metabolic surveillance and treatment. Case presentation: A 5.5-year-old Pakistani male child was referred for a muscular bodybuilder-like look since 24 months of age, chronic steatorrhea (4–5 times a day, aggravated by fat intake), hyperphagia, and poor growth. His birth was normal at term through a normal vaginal delivery and with normal weight and milestones. His family history was negative for lipodystrophy and metabolic disease. His weight (16 kg) and height (105 cm) were below 10th percentile with a BMI of 14.5 kg/m² (< 5th percentile). He had diffuse muscular hypertrophy with a complete loss of subcutaneous fat, visible veins, coarse face with facial lipoatrophy, abdominal distension with hepatomegaly (4 cm below the right costal margin, span 12 cm) and an everted umbilicus. There were no signs of acanthosis nigricans, xanthomas, hirsutism or splenomegaly. Real-Time PCR (RT-PCR) gene analysis confirmed CGL Type 2: BSCL2 exons 4 and 7 were detected; AGPAT2, CAV1, and PTRF were not detected. Both parents confirmed as carriers; all four siblings are unaffected (three heterozygous carriers, one non-carrier). Routine investigations showed macrocytic anaemia (Hb 10 g/dL, MCV 110.8 fL), raised transaminases (ALT 71 U/L, AST 97 U/L), grossly raised IgG (2727.98 mg/dL) and low IgA (4.39 mg/dL). Ultrasonography showed hepatic steatosis. Creatine phosphokinase (103 U/L) was normal, ruling out primary muscular dystrophy. IgA anti-tissue transglutaminase was negative, so coeliac disease was excluded. Hepatitis B, C and HIV were negative. Rickets and skeletal dysplasia were ruled out by a skeletal survey. Fasting triglycerides 862 mg/dL, serum leptin 0.4 ng/mL, and HOMA-IR 10.4 confirmed severe metabolic dysfunction characteristic of CGL2. Based on clinical and biochemical findings, RT-PCR confirmed the diagnosis of CGL type 2 (BSCL2; OMIM #269700) was made. A low-fat diet (20–30% of total energy) with medium-chain triglyceride supplementation, metabolic control and genetic counselling was started. Conclusions: This RT-PCR confirmed case of CGL2 demonstrates the triad of CGL: diffuse lipoatrophy with muscular hypertrophy, hepatomegaly secondary to steatosis, and steatorrhoea, with poor growth. To our knowledge, this is the first RT-PCR confirmed CGL2 case reported from Pakistan. Early diagnosis of this rare condition is important to start life-changing metabolic interventions that include dietary restriction, metreleptin replacement and treatment of dyslipidaemia, which may dramatically impact the disease progression and outcome in childhood.

  • Open Access

    Intravenous Terbutaline as Rescue Therapy in Severe Bronchiolitis: A Report of Two Cases

    by Wajiha Rizwan, Saba Urooj, Azher Abbas Shah, Adnan Tariq Bhutta

    Bronchiolitis is a lower respiratory tract infection most frequently caused by viral infections and is usually managed with supportive care. The role of bronchodilators particularly intravenous (IV) β2-agonists remain uncertain. Emerging evidence suggests that bronchiolitis comprises heterogeneous phenotypes, with a subset demonstrating bronchodilator responsiveness. We report two infants (ten and three months old) with RSV confirmed severe bronchiolitis who exhibited respiratory distress and hypoxemia despite maximal supportive therapy, including oxygen, continuous positive airway pressure (CPAP), corticosteroids and inhaled salbutamol. IV terbutaline was initiated as rescue therapy after failure of supportive treatment and titrated up to 0.4 µg/kg/min resulting in progressive improvement in clinical respiratory scores, resolution of wheeze, and normalization of oxygen saturation within 24-48 hours. No adverse effects were observed. These case reports highlight the potential role of IV terbutaline as a rescue therapy in selected infants with bronchiolitis associated bronchospasm and warrant further well designed larger prospective studies.

  • Letter to the Editor: Breastfeeding Support During Floods in Pakistan

    by Wajiha Rizwan, Masood Sadiq, Khalid Masood Gondal

  • Open Access

    Safety Profile of Sinopharm COVID-19 Vaccine and Breakthrough Infections in Pakistan

    by Wajiha Rizwan, Ahmad Uzair Qureshi, Muhammad Nasir Rana, Mubeen Nazar Duggal, Muhammad Sohaib, Masood Sadiq

    Background: To determine the safety profile of Sinopharm COVID-19 vaccine and identify breakthrough infections. Method: The study design was analytical cross sectional. An online questionnaire was filled by 1033 respondentsbetween 16th and 22nd April 2021. Adults who had received both doses of Sinopharm COVID-19 vaccine more than a week ago or only a single dose with serious side effect were included in the study. The frequency and severity of vaccination related side effects were assessed and breakthrough infection identified. Results: The mean age of participants was 36.7 ± 12.91(18 – 92) years. Ninety one percent of participants (n=946) were health care professionals. One fifth (n=225/1033, 21.8%) had suffered from COVID-19 infection prior to vaccination, confirmed using the nasal RT-PCR test. None of the participants reported serious (grade III) or life threatening (grade IV) adverse reactions after either of the two doses. The most common side effects after the first dose were pain at injection site (20.3%), fatigue (20.3%), headache (13.9%), myalgia (12.5%) and fever (9.3%) whereas after the second dose were fatigue (16.8%), pain at injection site (15.8%), myalgia (14%) and fever (6.7%). The side effects were more common in participants who had previous history of COVID-19 infection. Of 225 previously infected participants, 97(43.1%) (p value=0.020) and 90 (40%) (p value=0.001) participants had side effects after 1 st and 2 nd dose respectively. 16 participants (1.55%) developed PCR positive COVID-19 infection two weeks after the second dose while 3(0.29%) participants had a re-infection. There was one case of probable severe COVID-19 infection, 2 weeks after the second dose and recovered completely with treatment. Conclusion: Our study shows that Sinopharm COVID-19 vaccine is generally safe with no serious side effects. The side effects were however, more common in inviduals who already had COVID-19 infection. The COVID-19 breakthrough infection and reinfection could occur after the vaccination.


  • Open Access

    Acceptance of COVID-19 Vaccine in Pakistan: A Nationwide Cross-Sectional Study

    by Mohammad Aadil Qamar, Omar Irfan, Rubaid A Dhillon, Areesh Bhatti, Mir Ibrahim Sajid, Safia Awan, Wajiha Rizwan, Ali Bin Sarwar Zubairi, Zouina Sarfraz, Javaid Ahmed Khan

    Introduction The coronavirus disease 2019 (COVID-19) vaccine is available across various countries worldwide, with public-private partnerships ensuring all individuals are vaccinated through a phased approach. Irrespective of the geographical spread, several myths pertaining to the COVID-19 vaccine have stemmed, ultimately limiting the national administration of vaccines and rollouts. This study assessed the acceptance of the COVID-19 vaccine among the general public in Pakistan. Methods A pre-validated questionnaire was administered from January 2(121 to February 2021 to assess the public attitude and acceptance of the COVID-19 vaccine. Logistic regression analyses were run to identify factors associated with the acceptance among the population. Results A total of 936 responses were elicited, where 15% perceived their risk of being infected at 20-30% with an overall 70% agreeing to be vaccinated if recommended. Multivariate analysis identified higher acceptance in the male gender, healthcare workers, and students. Of all, 66% respondents chose healthcare workers and public officials, whereas 15.6% chose scientific literature, and 12.9% chose social media as the most reliable source of COVID-19 information. Conclusion Given the relatively greater trust in healthcare providers for information regarding COVID-19, healthcare workers ought to be on the frontline for vaccine campaigns and public outreach efforts, with governmental efforts in addition to the promotion of scientific materials for population-level understanding.


  • Open Access

    Etiology of fever of unknown origin in children.

    by Aysha Mansoor Lodhi, Wajiha Rizwan, Mubeen Nazar, Asma Mushtaq, Muhammad Sahir Saud, Shahida Perveen

    Objectives: To determine the etiology of Fever of Unknown Origin (FUO) in children. Study Design: Prospective Observational study. Setting: Department of Pediatric Medicine, The Children's Hospital, Lahore. Period: August 2019 to January 2020. Material & Methods: A total of 45 children aged between 01 to 180 months (15 years), having FUO were included. FUO was defined as a temperature of greater than 100.4ºF documented by a health care provider, persisting over a period of three weeks and for which no cause could be identified after at least 8 days of evaluation. All the study information was analyzed by using standard software SPSS 20. The quantitative variables like age and duration of fever before hospital admission were presented as mean and standard deviation. Qualitative variables like sex, antibiotic therapy use before definitive diagnosis and various diagnoses made were presented as frequencies and percentages. Results: The patient’s age range was from 01 to 180 months with mean of 80±45.12 months and male to female ratio was 2.2:1. Definitive diagnosis was made in 37(82.2%) patients. Infections were the predominant cause of FUO (44.4%) followed by malignancy (24.4%). Tuberculosis was the most common infection while Acute Lymphoblastic leukemia dominated the malignancy. Systemic lupus erythematosus was the most commonly diagnosed connective tissue disorder. There was a significant association between duration of fever and the ultimate diagnosis (p=0.01). Conclusion: Infectious diseases were the most common cause of FUO followed by malignancy, connective tissue disorders and miscellaneous causes.